# Delaware Clinical and Translational Research ACCEL Program (Pilot Core)

> **NIH NIH U54** · UNIVERSITY OF DELAWARE · 2023 · $1,363,566

## Abstract

ABSTRACT- PILOT PROJECTS PROGRAM
The ACCEL-CTR Program has established an exceptionally strong network of clinicians and scientists that is
enhancing clinical and translational research within the state of Delaware. In ACCEL3, our third funding cycle,
we will continue to broaden our impact while also sharpening our focus in key areas including the creation of
sustainable infrastructure for clinical and translational research in Delaware, the establishment of a scientific
culture that values diversity and incorporates health equity as a focus, and the expansion of community
engaged research. In this renewal, the Pilot Projects Program (PPP) will grow and evolve based on past
successes, lessons learned, and responding to investigator and community needs. The Specific Aims of the
PPP are to (1) inspire and support clinical and translational research; (2) facilitate high-impact interdisciplinary
collaborations; and (3) help investigators overcome barriers in successful translation across the research
continuum. We will fund a wide variety of types of awards, including standard pilot grants, pilot grants
specifically targeting community-engaged research, interdisciplinary grants, mentored awards, and larger
grants for infrastructure. In direct support of the overall mission, the PPP will put in place new requirements
related to diversity, health equity, and community engagement. Evaluation of applications will be conducted by
peer-review by qualified and NIH-experienced members of the scientific community using review and scoring
mechanisms modeled after the NIH. We will prioritize clinical and community engaged research as well as
projects addressing conditions that affect the medically underserved or disproportionately affect the health of
Delawareans. The PPP will continue to synergize with the other ACCEL cores to leverage professional
development opportunities, community engagement and outreach functions, and other facilities and services to
maximize the training and career development of our pilot awardees. The PPP will be led by Susanne Morton
and supported by the ACCEL Research Committee, with representation from all partner institutions, and
administrative staff. In ACCEL3, the PPP will continue to be an integral CTR core, catalyzing collaborative and
community-based clinical and translational research for the benefit of all Delawareans.

## Key facts

- **NIH application ID:** 10721013
- **Project number:** 2U54GM104941-11
- **Recipient organization:** UNIVERSITY OF DELAWARE
- **Principal Investigator:** Susanne M Morton
- **Activity code:** U54 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2023
- **Award amount:** $1,363,566
- **Award type:** 2
- **Project period:** 2013-09-25 → 2028-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10721013

## Citation

> US National Institutes of Health, RePORTER application 10721013, Delaware Clinical and Translational Research ACCEL Program (Pilot Core) (2U54GM104941-11). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10721013. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*